Literature DB >> 31177220

Locus Coeruleus Degeneration Induces Forebrain Vascular Pathology in a Transgenic Rat Model of Alzheimer's Disease.

Sarah C Kelly1,2, Erin C McKay1,3, John S Beck1, Timothy J Collier1,2,3, Anne M Dorrance3,4, Scott E Counts1,2,3,5,6,7.   

Abstract

Noradrenergic locus coeruleus (LC) neuron loss is a significant feature of mild cognitive impairment and Alzheimer's disease (AD). The LC is the primary source of norepinephrine in the forebrain, where it modulates attention and memory in vulnerable cognitive regions such as prefrontal cortex (PFC) and hippocampus. Furthermore, LC-mediated norepinephrine signaling is thought to play a role in blood-brain barrier (BBB) maintenance and neurovascular coupling, suggesting that LC degeneration may impact the high comorbidity of cerebrovascular disease and AD. However, the extent to which LC projection system degeneration influences vascular pathology is not fully understood. To address this question in vivo, we stereotactically lesioned LC projection neurons innervating the PFC of six-month-old Tg344-19 AD rats using the noradrenergic immunotoxin, dopamine-β-hydroxylase IgG-saporin (DBH-sap), or an untargeted control IgG-saporin (IgG-sap). DBH-sap-lesioned animals performed significantly worse than IgG-sap animals on the Barnes maze task in measures of both spatial and working memory. DBH-sap-lesioned rats also displayed increased amyloid and inflammation pathology compared to IgG-sap controls. However, we also discovered prominent parenchymal albumin extravasation with DBH-sap lesions indicative of BBB breakdown. Moreover, microvessel wall-to-lumen ratios were increased in the PFC of DBH-sap compared to IgG-sap rats, suggesting that LC deafferentation results in vascular remodeling. Finally, we noted an early emergence of amyloid angiopathy in the DBH-sap-lesioned Tg344-19 AD rats. Taken together, these data indicate that LC projection system degeneration is a nexus lesion that compromises both vascular and neuronal function in cognitive brain areas during the prodromal stages of AD.

Entities:  

Keywords:  Alzheimer’s disease; blood-brain barrier; cerebral amyloid angiopathy; locus coeruleus; vascular remodeling

Mesh:

Year:  2019        PMID: 31177220      PMCID: PMC6929678          DOI: 10.3233/JAD-190090

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  130 in total

Review 1.  Adrenergic pharmacology and cognition: focus on the prefrontal cortex.

Authors:  Brian P Ramos; Amy F T Arnsten
Journal:  Pharmacol Ther       Date:  2006-12-28       Impact factor: 12.310

Review 2.  Functional neuroanatomy of the central noradrenergic system.

Authors:  Elemer Szabadi
Journal:  J Psychopharmacol       Date:  2013-06-12       Impact factor: 4.153

3.  Blood-brain barrier protein recognized by monoclonal antibody.

Authors:  N H Sternberger; L A Sternberger
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 4.  Central adrenergic regulation of cerebral microvascular permeability and blood flow; anatomic and physiologic evidence.

Authors:  B K Hartman; L W Swanson; M E Raichle; S H Preskorn; H B Clark
Journal:  Adv Exp Med Biol       Date:  1980       Impact factor: 2.622

5.  Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory.

Authors:  Kimberly A Kempadoo; Eugene V Mosharov; Se Joon Choi; David Sulzer; Eric R Kandel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-07       Impact factor: 11.205

Review 6.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

Review 7.  Astrocytes: targets for neuroprotection in stroke.

Authors:  George Barreto; Robin E White; Yibing Ouyang; Lijun Xu; Rona G Giffard
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2011-06-01

8.  Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus.

Authors:  V R Holets; T Hökfelt; A Rökaeus; L Terenius; M Goldstein
Journal:  Neuroscience       Date:  1988-03       Impact factor: 3.590

Review 9.  Mechanisms underlying blood-brain barrier dysfunction in brain pathology and epileptogenesis: role of astroglia.

Authors:  Richard Kovács; Uwe Heinemann; Christian Steinhäuser
Journal:  Epilepsia       Date:  2012-11       Impact factor: 5.864

10.  Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort.

Authors:  A Smallwood; A Oulhaj; C Joachim; S Christie; C Sloan; A D Smith; M Esiri
Journal:  Neuropathol Appl Neurobiol       Date:  2012-06       Impact factor: 8.090

View more
  5 in total

1.  Pontine Arteriolosclerosis and Locus Coeruleus Oxidative Stress Differentiate Resilience from Mild Cognitive Impairment in a Clinical Pathologic Cohort.

Authors:  Sarah C Kelly; Peter T Nelson; Scott E Counts
Journal:  J Neuropathol Exp Neurol       Date:  2021-03-22       Impact factor: 3.148

Review 2.  Locus Coeruleus Magnetic Resonance Imaging in Neurological Diseases.

Authors:  Alessandro Galgani; Francesco Lombardo; Daniele Della Latta; Nicola Martini; Ubaldo Bonuccelli; Francesco Fornai; Filippo Sean Giorgi
Journal:  Curr Neurol Neurosci Rep       Date:  2020-12-12       Impact factor: 5.081

3.  Stereological Changes in Microvascular Parameters in Hippocampus of a Transgenic Rat Model of Alzheimer's Disease.

Authors:  Yaroslav Kolinko; Lucie Marsalova; Stephanie Proskauer Pena; Milena Kralickova; Peter R Mouton
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA): Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease-Opportunities for Therapy.

Authors:  Roxana O Carare; Roxana Aldea; Nivedita Agarwal; Brian J Bacskai; Ingo Bechman; Delphine Boche; Guojun Bu; Diederik Bulters; Alt Clemens; Scott E Counts; Mony de Leon; Per K Eide; Silvia Fossati; Steven M Greenberg; Edith Hamel; Cheryl A Hawkes; Maya Koronyo-Hamaoui; Atticus H Hainsworth; David Holtzman; Masafumi Ihara; Angela Jefferson; Raj N Kalaria; Christopher M Kipps; Katja M Kanninen; Ville Leinonen; JoAnne McLaurin; Scott Miners; Tarja Malm; James A R Nicoll; Fabrizio Piazza; Gesine Paul; Steven M Rich; Satoshi Saito; Andy Shih; Henrieta Scholtzova; Heather Snyder; Peter Snyder; Finnbogi Rutur Thormodsson; Susanne J van Veluw; Roy O Weller; David J Werring; Donna Wilcock; Mark R Wilson; Berislav V Zlokovic; Ajay Verma
Journal:  Alzheimers Dement (Amst)       Date:  2020-08-03

Review 5.  Saporin from Saponaria officinalis as a Tool for Experimental Research, Modeling, and Therapy in Neuroscience.

Authors:  Alexey P Bolshakov; Mikhail Yu Stepanichev; Yulia V Dobryakova; Yulia S Spivak; Vladimir A Markevich
Journal:  Toxins (Basel)       Date:  2020-08-25       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.